Literature DB >> 25753261

Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion.

J S Raval1, M A Mazepa, S L Russell, C C Immel, H C Whinna, Y A Park.   

Abstract

BACKGROUND: Transfusion-associated circulatory overload (TACO) is the second leading cause of reported transfusion-related fatalities in the United States. While its occurrence has been previously investigated after red cell and plasma transfusion, no data are available regarding its association with platelet transfusion. Our goal was to determine the rate of platelet-associated TACO at our university medical centre. STUDY DESIGN AND METHODS: This study had retrospective and prospective analyses. The 13-year retrospective analysis served to determine the historical rate of platelet-associated TACO by passive reporting. The 30-day prospective analysis included active surveillance of all non-emergently issued and non-operative platelet recipients ≥16 years old with no transfusions in the previous 6 h determined by analysis of blood bank product issue records. Data collected included demographics, vital signs pre- and posttransfusion, fluid balances, supplemental oxygen use, reports of dyspnoea, and infusion rates. For the prospective analysis, all variables were collected within 24 h of transfusion from the medical record and, when necessary, interviews with care providers and/or patients.
RESULTS: In the retrospective analysis, 366 reactions were reported, of which 6 (1·6%) were TACO. The historical rate of TACO was 1:5997 transfused platelet units. During the prospective analysis, 225 eligible patients received a total of 334 units of platelets. The average platelet transfusion volume was 261 ± 26 ml, and the average infusion rate was 391 ± 198 ml/h. Two unreported TACO reactions were discovered and characterized by new-onset hypertension, crackles on lung auscultation, dyspnoea, hypoxia and supplemental oxygen requirements which resolved completely with diuresis. The rate of TACO during this prospective analysis was 1:167 transfused platelet units.
CONCLUSION: Platelet-associated TACO is greatly underestimated by passive reporting in the adult patient population.
© 2015 International Society of Blood Transfusion.

Entities:  

Keywords:  platelet; transfusion; transfusion-associated circulatory overload; volume overload

Mesh:

Year:  2015        PMID: 25753261     DOI: 10.1111/vox.12234

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  14 in total

1.  Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload.

Authors:  Nareg H Roubinian; Jeanne E Hendrickson; Darrell J Triulzi; Jerome L Gottschall; Michael Michalkiewicz; Dhuly Chowdhury; Daryl J Kor; Mark R Looney; Michael A Matthay; Steven H Kleinman; Donald Brambilla; Edward L Murphy
Journal:  Crit Care Med       Date:  2018-04       Impact factor: 7.598

2.  Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Authors:  Asma Ashraf; Andreas V Hadjinicolaou; Carolyn Doree; Sally Hopewell; Marialena Trivella; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

3.  Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm.

Authors:  N H Roubinian; J E Hendrickson; D J Triulzi; J L Gottschall; D Chowdhury; D J Kor; M R Looney; M A Matthay; S H Kleinman; D Brambilla; E L Murphy
Journal:  Vox Sang       Date:  2016-12-21       Impact factor: 2.144

Review 4.  Transfusion as a Palliative Strategy.

Authors:  Jay S Raval
Journal:  Curr Oncol Rep       Date:  2019-08-30       Impact factor: 5.075

5.  Oncology Patients Who Develop Transfusion-Associated Circulatory Overload: An Observational Study.

Authors:  Marisol Maldonado; Colleen E Villamin; Leah E Murphy; Amitava Dasgupta; Roland L Bassett; Mayrin Correa Medina; Tonita S Bates; Fernando Martinez; Adriana M Knopfelmacher Couchonal; Kimberly Klein; James M Kelley
Journal:  Lab Med       Date:  2022-07-04

6.  Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication.

Authors:  Jeanne E Hendrickson; Nareg H Roubinian; Dhuly Chowdhury; Don Brambilla; Edward L Murphy; Yanyun Wu; Paul M Ness; Eric A Gehrie; Edward L Snyder; R George Hauser; Jerome L Gottschall; Steve Kleinman; Ram Kakaiya; Ronald G Strauss
Journal:  Transfusion       Date:  2016-07-26       Impact factor: 3.157

Review 7.  Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Authors:  Reem Malouf; Asma Ashraf; Andreas V Hadjinicolaou; Carolyn Doree; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2018-05-14

8.  Plasma Transfusion Practice in Adult Surgical Patients: Systematic Review of the Literature.

Authors:  Elisabeth Hannah Adam; Dania Fischer
Journal:  Transfus Med Hemother       Date:  2020-09-18       Impact factor: 3.747

9.  Fibrinogen-Coated Albumin Nanospheres Prevent Thrombocytopenia-Related Bleeding.

Authors:  Anthony D Sung; Richard C Yen; Yiqun Jiao; Alyssa Bernanke; Deborah A Lewis; Sara E Miller; Zhiguo Li; Joel R Ross; Alexandra Artica; Sadhna Piryani; Dunhua Zhou; Yang Liu; Tuan Vo-Dinh; Maureane Hoffman; Thomas L Ortel; Nelson J Chao; Benny J Chen
Journal:  Radiat Res       Date:  2020-08-01       Impact factor: 3.372

10.  The use of transfusion quality indicators as a tool for hemovigilance system implementation at a tertiary care center in Saudi Arabia.

Authors:  Salwa I Hindawi; Maha A Badawi; Edwin T Raj; Kholoud A Gholam; Seraj O Al-Weail; Fatima Azher
Journal:  Saudi Med J       Date:  2016-05       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.